Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

133.92
Delayed Data
As of Jul 27
 +2.85 / +2.17%
Today’s Change
96.18
Today|||52-Week Range
145.42
+9.46%
Year-to-Date

Today’s Trading

Previous close131.07
Today’s open139.00
Day’s range132.24 - 142.47
Volume5,175,499
Average volume (3 months)2,758,361
Market cap$29.4B
Dividend yield--
Data as of 4:00pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+14.91%
Earnings growth (next 5 years)+21.00%
Revenue growth (last year)+21.11%
P/E ratio63.8
Price/Sales9.22
Price/Book3.38

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.05-0.08%
INCYIncyte Corp-4.47-3.26%
BAXBaxter International...-0.84-1.37%
MYLMylan NV-0.70-1.79%
Data as of 4:01pm ET, 07/27/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.33
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts